
Video Link: https://vimeo.com/286856470
Video Download: Researchers Ponder Why Estrogen Only Hrt May Reduce Breast Cancer Risk
Video Stream: Researchers Ponder Why Estrogen Only Hrt May Reduce Breast Cancer Risk
Breast cancer risk may decline in postmenopausal women who take estrogen-only Hormone Replacement Therapy (HRT); a review released Thursday concludes.
That represents a substantial change from how estrogen-only hormone therapy was viewed a decade ago, the authors said.
Older observational studies suggested that both of the primary forms of hormone therapy -- estrogen-only for women who have had hysterectomies and an estrogen-progestin combination for women with uteruses -- raised breast cancer risk.
The landmark Women's Health Initiative found that the estrogen-progestin combination did significantly increase the possibility of breast cancer in postmenopausal women. However, the estrogen-alone arm of the study was inconclusive.
A reanalysis of data from that study published earlier this month found that estrogen-only did not raise the risk of breast cancer and even lowered it in women who do not have risk factors for the disease, such as a family history or a history of benign breast disease.
The new review, led by Dr. Rowan T. Chlebowski of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, again examined the Women's Health Initiative data.
They concluded that estrogen-alone significantly decreased the risk of breast cancer while estrogen-progestin significantly increased the risk.
A couple of points about hormone therapy and breast cancer are coming into focus.
One is that some of the observational studies of decades past indicating that estrogen-alone increased breast cancer may have been skewed by the fact that hormone users were also more likely to get mammograms and have their cancers detected, the authors said.
Second, it appears that breast cancer cells in postmenopausal women are highly sensitive to changes in levels of hormones and "can survive only a limited range of estrogen exposures," they said.
A substantial change in estrogen levels can halt tumor growth.
If you're a postmenopausal woman and are confused, no wonder.
As the authors state: "[C]oncepts regarding menopausal hormone therapy and breast cancer have undergone considerable change in the last decade."
Women with uncomfortable menopausal symptoms should talk to their doctors about treatment options.
Estrogen-progestin for women with uteruses will increase breast cancer risk, but women who have had hysterectomies have more choices. For everyone, Hormone Replacement Therapy involves weighing some risks and benefits.
The paper appears in the Journal of the National Cancer Institute.
Contact us for a FREE, no-obligation discussion of Hormone Replacement Therapy.
Reference
Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative
Contact Us Today For A Free Consultation
Dear Patient,
Once you have completing the above contact form, for security purposes and confirmation, please confirm your information by calling us.
Please call now: 1-800-380-5339.
Welcoming You To Our Clinic, Professor Tom Henderson.

- Slow Aging with Growth Hormone - July 17th, 2022
- Cheaping Out on HGH Therapy – JUST DON’T DO IT - July 12th, 2022
- Hormone Impacts And Function Of HGH - July 10th, 2022
- General Physician Versus Hormone Specialist – Some Symptoms Require a Specialist to Heal - March 18th, 2022
- An Introduction to Growth Hormone - October 27th, 2021
- Growth Hormone and Pneumonia - October 27th, 2021
- Growth Hormone and Testosterone Replacement Therapy - October 27th, 2021
- Growth Hormone and the Hypothalamus Gland - October 27th, 2021
- Growth Hormone and the Law - October 27th, 2021
- Growth Hormone and Gene Therapy - October 26th, 2021
- What Men Need To Know About Testosterone And Growth Hormone - October 26th, 2021
- Growth Hormone Explained - October 26th, 2021
- The Best Ways to Boost Growth Hormone - October 26th, 2021
- Growth Hormone Sprays - October 26th, 2021
- Growth Hormone Dosage - October 26th, 2021
- Insulin-Similar Growth Factor Benefits - October 26th, 2021
- The Benefits of IGF-1 - October 26th, 2021
- Hormone Replacement Therapy is Safe - October 26th, 2021
- Growth Hormone Therapy Reverses Biological Age In Groundbreaking Study - October 25th, 2021
- Human Growth Hormone Secretagogue: Sermorelin - October 25th, 2021
- Early Hormone Replacement Therapy May Lower Alzheimer Risk - October 25th, 2021
- Comprehensive Hormone Replacement Therapy with Tesamorelin - September 18th, 2021
- Risks of Hormones in Early Menopause Challenged - August 24th, 2021
- Heart Benefits From Hormone Replacement Therapy? - August 18th, 2021
- New Research: Cognitive Therapy Could Reduce Menopausal Hot Flashes - August 16th, 2021
- A Toxic Hormone is Altering the Sex and Reproduction of Aquatic Life in United States Streams - August 16th, 2021
- Act Now to Prevent the Increasingly Common Condition of Hypothyroidism - June 21st, 2021
- The HGH Recommended Medical Dosage - The Importance of Blood Work - May 25th, 2021
- Hormone Replacement Therapy Safe, Study Suggests - May 24th, 2021
- HGH Secretagogue - May 22nd, 2021
- Androgel : Men Getting Their Mojo Back! - May 21st, 2021
- Hormone Therapy May Help Cut Alzheimer's Risk - May 18th, 2021
- Finally Explained: The Mysterious Pineal Gland - April 30th, 2021
- Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy - April 14th, 2021
- Andropause From The Wikipedia Encyclopedia - April 12th, 2021
- The Importance of Luteinizing Hormone - April 11th, 2021
- Melatonin: The Body's Master Clock - April 8th, 2021
- LCN2 Hormone Suppresses Hunger and Discourages Overeating - April 7th, 2021
- New Research on Hormone Replacement Therapy - March 12th, 2021


